| Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis Cross-Disorder Group of the Psychiatric Genomics Consortium The Lancet 381 (9875), 1371-1379, 2013 | 3134 | 2013 |
| Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs B Devlin, JR Kelsoe, P Sklar, MJ Daly, MC O'Donovan, N Craddock, ... Nature genetics 45 (9), 984-994, 2013 | 2423 | 2013 |
| Genome-wide association study identifies five new schizophrenia loci Nature genetics 43 (10), 969-976, 2011 | 2068 | 2011 |
| Large recurrent microdeletions associated with schizophrenia H Stefansson, D Rujescu, S Cichon, OPH Pietiläinen, A Ingason, ... nature 455 (7210), 232-236, 2008 | 2046 | 2008 |
| Common variants conferring risk of schizophrenia H Stefansson, RA Ophoff, S Steinberg, OA Andreassen, S Cichon, ... Nature 460 (7256), 744-747, 2009 | 1990 | 2009 |
| Genome-wide association analysis identifies 13 new risk loci for schizophrenia S Ripke, C O'dushlaine, K Chambert, JL Moran, AK Kähler, S Akterin, ... Nature genetics 45 (10), 1150-1159, 2013 | 1795 | 2013 |
| Cannabis abuse and the course of recent-onset schizophrenic disorders DH Linszen, PM Dingemans, ME Lenior Archives of general psychiatry 51 (4), 273-279, 1994 | 1014 | 1994 |
| Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study S Ruhrmann, F Schultze-Lutter, RKR Salokangas, M Heinimaa, D Linszen, ... Archives of general psychiatry 67 (3), 241-251, 2010 | 815 | 2010 |
| Genomic dissection of bipolar disorder and schizophrenia, including 28 subphenotypes DM Ruderfer, S Ripke, A McQuillin, J Boocock, EA Stahl, JMW Pavlides, ... Cell 173 (7), 1705-1715. e16, 2018 | 704 | 2018 |
| The environment and schizophrenia: the role of cannabis use C Henquet, R Murray, D Linszen, J van Os Schizophrenia bulletin 31 (3), 608-612, 2005 | 639 | 2005 |
| Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways B Devlin, JR Kelsoe, P Sklar, MJ Daly, MC O'Donovan, N Craddock, ... Nature neuroscience 18 (2), 199-209, 2015 | 626 | 2015 |
| Preventing a first episode of psychosis: meta-analysis of randomized controlled prevention trials of 12 month and longer-term follow-ups M Van Der Gaag, F Smit, A Bechdolf, P French, DH Linszen, AR Yung, ... Schizophrenia research 149 (1-3), 56-62, 2013 | 494 | 2013 |
| The validity of the 16-item version of the Prodromal Questionnaire (PQ-16) to screen for ultra high risk of developing psychosis in the general help-seeking population HK Ising, W Veling, RL Loewy, MW Rietveld, J Rietdijk, S Dragt, ... Schizophrenia bulletin 38 (6), 1288-1296, 2012 | 463 | 2012 |
| Treatment, expressed emotion and relapse in recent onset schizophrenic disorders D Linszen, P Dingemans, JW Van der Does, A Nugter, P Scholte, ... Psychological medicine 26 (2), 333-342, 1996 | 309 | 1996 |
| Interventions to improve adherence to antipsychotic medication in patients with schizophrenia–a review of the past decade E Barkhof, CJ Meijer, LMJ de Sonneville, DH Linszen, L de Haan European psychiatry 27 (1), 9-18, 2012 | 302 | 2012 |
| Cognitive behavioral therapy for subjects at ultrahigh risk for developing psychosis: a randomized controlled clinical trial M van der Gaag, DH Nieman, J Rietdijk, S Dragt, HK Ising, RMC Klaassen, ... Schizophrenia bulletin 38 (6), 1180-1188, 2012 | 272 | 2012 |
| Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis E Velthorst, DH Nieman, HE Becker, R van de Fliert, PM Dingemans, ... Schizophrenia research 109 (1-3), 60-65, 2009 | 263 | 2009 |
| Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group J Assies, R Lieverse, P Vreken, RJA Wanders, PMJA Dingemans, ... Biological psychiatry 49 (6), 510-522, 2001 | 245 | 2001 |
| Joint analysis of psychiatric disorders increases accuracy of risk prediction for schizophrenia, bipolar disorder, and major depressive disorder R Maier, G Moser, GB Chen, S Ripke, D Absher, I Agartz, H Akil, F Amin, ... The American Journal of Human Genetics 96 (2), 283-294, 2015 | 243 | 2015 |
| Mental health research priorities for Europe T Wykes, JM Haro, SR Belli, C Obradors-Tarragó, C Arango, ... The Lancet Psychiatry 2 (11), 1036-1042, 2015 | 223 | 2015 |
